Cancer Letters
Volume 229, Issue 1 , Pages 85-91 , 8 November 2005

GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer

  • Rikke Hansen

      Affiliations

    • National Institute of Occupational Health, Copenhagen, Denmark
    • ,
  • Mona Sæbø

      Affiliations

    • Department of Environmental and Health Studies, Faculty of Arts and Sciences, Telemark University College, Hallvard Eikas plass, Bø i Telemark N-3800, Norway
    • Mona Sæbø and Camilla Furu Skjelbred have contributed equally.
    • ,
  • Camilla Furu Skjelbred

      Affiliations

    • Department of Environmental and Health Studies, Faculty of Arts and Sciences, Telemark University College, Hallvard Eikas plass, Bø i Telemark N-3800, Norway
    • Department of Occupational and Environmental Medicine, Telemark Hospital, Skien, Norway
    • Mona Sæbø and Camilla Furu Skjelbred have contributed equally.
    • ,
  • Bjørn Andersen Nexø

      Affiliations

    • Institute of Human Genetics, University of Aarhus, Aarhus, Denmark
    • ,
  • Per Christian Hagen

      Affiliations

    • Department of Environmental and Health Studies, Faculty of Arts and Sciences, Telemark University College, Hallvard Eikas plass, Bø i Telemark N-3800, Norway
    • ,
  • Günther Bock

      Affiliations

    • Department of Surgery, Telemark Hospital, Skien, Norway
    • ,
  • Inger Marie Bowitz Lothe

      Affiliations

    • Department of Pathology, Ullevaal University Hospital, Oslo, Norway
    • ,
  • Egil Johnson

      Affiliations

    • Department of Gastroenterological Surgery, Ullevaal University Hospital, Oslo, Norway
    • ,
  • Steinar Aase

      Affiliations

    • Department of Pathology, The Gade Institute, Haukeland University Hospital, N-5021 Bergen, Norway
    • ,
  • Inger-Lise Hansteen

      Affiliations

    • Department of Occupational and Environmental Medicine, Telemark Hospital, Skien, Norway
    • ,
  • Ulla Vogel

      Affiliations

    • National Institute of Occupational Health, Copenhagen, Denmark
    • ,
  • Elin H. Kure

      Affiliations

    • Department of Environmental and Health Studies, Faculty of Arts and Sciences, Telemark University College, Hallvard Eikas plass, Bø i Telemark N-3800, Norway
    • Department of Pathology, Ullevaal University Hospital, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Address: Department of Environmental and Health Studies, Faculty of Arts and Sciences, Telemark University College, Hallvard Eikas plass, Bø i Telemark N-3800, Norway. Tel.: +47 3595 2500; fax: +47 3595 2703.

Received 20 February 2005 ,Revised 10 April 2005 ,Accepted 15 April 2005.

References 

  1. Kondo S, Toyokuni S, Tanaka T, Hiai H, Onodera H, Kasai H, et al. Overexpression of the hOGG1 gene and high 8-hydroxy-2′-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: regulation mechanism of the 8-OHdG level in DNA. Clin. Cancer Res. 2000;6:1394–1400
  2. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA. 1999;96:13300–13305
  3. Roldan-Arjona T, Wei YF, Carter KC, Klungland A, Anselmino C, Wang RP, et al. Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase. Proc. Natl. Acad. Sci. USA. 1997;94:8016–8020
  4. Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 1997;94:8010–8015
  5. Aburatani H, Hippo Y, Ishida T, Takashima R, Matsuba C, Kodama T, et al. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res. 1997;57:2151–2156
  6. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Huntingt). 2002;16:217–226(see also 229)
  7. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, et al. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res. 2004;64:962–968
  8. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003;63:3347–3351
  9. Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, Taylor PR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 2000;60:6381–6383
  10. Cox DG, Hankinson SE, Kraft P, Hunter DJ. No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2004;13:1821–1822
  11. Vogel U, Olsen A, Wallin H, Overvad K, Tjonneland A, Nexo BA. No association between GPX Pro198Leu and risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2004;13:1412–1413
  12. Yamane A, Kohno T, Ito K, Sunaga N, Aoki K, Yoshimura K, et al. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis. 2004;25:1689–1694
  13. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, et al. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc. Natl. Acad. Sci. USA. 2000;97:4156–4161
  14. Sakumi K, Tominaga Y, Furuichi M, Xu P, Tsuzuki T, Sekiguchi M, et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res. 2003;63:902–905
  15. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–3225
  16. Janssen K, Schlink K, Gotte W, Hippler B, Kaina B, Oesch F. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat. Res. 2001;486:207–216
  17. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis. 2002;23:1229–1234
  18. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002;11:409–412
  19. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, Dienemann H, et al. hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a Caucasian population. Int. J. Cancer. 2000;88:932–937
  20. Vogel U, Nexo BA, Wallin H, Overvad K, Tjonneland A, Raaschou-Nielsen O. No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem. Genet. 2004;42:453–460
  21. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol. Biomarkers Prev. 2002;11:730–738
  22. Kim JI, Park YJ, Kim KH, Kim JI, Song BJ, Lee MS, et al. hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J. Gastroenterol. 2003;9:956–960
  23. Vogel U, Nexo BA, Olsen A, Thomsen B, Jacobsen NR, Wallin H, et al. No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2003;12:170–171
  24. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J. Clin. Pathol. 1982;35:830–841
  25. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years. Scand. J. Gastroenterol. 2003;38:635–642
  26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215
  27. The Cancer Registry of Norway. Cancer in Norway 2001. Oslo: InfoPrint as; 2004;
  28. Hanaoka T, Sugimura H, Nagura K, Ihara M, Li XJ, Hamada GS, et al. hOGG1 exon7 polymorphism and gastric cancer in case–control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Lett. 2001;170:53–61
  29. Ito H, Hamajima N, Takezaki T, Matsuo K, Tajima K, Hatooka S, et al. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J. Epidemiol. 2002;12:258–265
  30. Starinsky S, Figer A, Ben Asher E, Geva R, Flex D, Fidder HH, et al. Genotype phenotype correlations in Israeli colorectal cancer patients. Int. J. Cancer. 2005;114:58–73
  31. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial. Euro. J. Cancer. 2005;
  32. Xie Y, Yang H, Cunanan C, Okamoto K, Shibata D, Pan J, et al. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res. 2004;64:3096–3102
  33. Russo MT, De Luca G, Degan P, Parlanti E, Dogliotti E, Barnes DE, et al. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res. 2004;64:4411–4414
  34. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ. XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 2004;13:1090–1091
  35. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet. 2002;11:1399–1407
  36. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case–control study. Int. J. Cancer. 2001;92:562–567
  37. Rafii S, O'Regan P, Xinarianos G, Azmy I, Stephenson T, Reed M, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum. Mol. Genet. 2002;11:1433–1438

PII: S0304-3835(05)00393-9

doi: 10.1016/j.canlet.2005.04.019

Cancer Letters
Volume 229, Issue 1 , Pages 85-91 , 8 November 2005

Article Tools